RESUMO
This work aims to define the aggression in all its forms, with notes on management and rapid tranquilization. The pathological aggression is described as a non-homogeneous phenomenon, it is variable in according to social, psychological and biological agents. The distinction of violence between affective aggression and predatory aggression can be functional to the prediction of outcome of any treatment. In general, a pattern of predatory violence tend to match with patients unresponsive and not compliant to treatment, a low probability to predict future violence and, therefore, a difficulty in managing risk. The affective aggressor, however, shows increased probability of treatment response, with more predictability of violent actions in reaction to situations perceived as threatening and, therefore, greater management of future violence risk. Those who act affective violence tend to show a wide range of emotional and cognitive problems, while those who act with predatory patterns show greater inclination to aggression and antisocial behavior. Aggression that occurs in psychiatry mostly appears to be affective, therefore susceptible to modulation through treatments.
Assuntos
Agressão/fisiologia , Agressão/psicologia , Transtornos Mentais/diagnóstico , Transtornos Mentais/terapia , Violência/psicologia , Humanos , Transtornos Mentais/fisiopatologia , Transtornos Mentais/psicologia , Pessoa de Meia-IdadeRESUMO
In PTSD, sleep disorders represent an important symptoms dimension which is associated with more severe PTSD and increased risk of relapse. The basic treatment for PTSD is not always associated to an improvement of sleep disturbances and nightmares. Alpha-blockers, and more specifically Prazosin, have shown a specific action on sleep disorders in PTSD. We report the clinical case of a young women with PTSD, who was suffering from severe sleep disorder and distressing nightmare. The patient was treated with Terazosin, a conger of Prazosin, and has shown symptom remission. Further studies on the use of alpha-blokers might reveal new therapeutic options in PTSD.
Assuntos
Antagonistas de Receptores Adrenérgicos alfa 1/uso terapêutico , Sonhos/efeitos dos fármacos , Prazosina/análogos & derivados , Transtornos do Sono-Vigília/tratamento farmacológico , Transtornos de Estresse Pós-Traumáticos/tratamento farmacológico , Neurônios Adrenérgicos/fisiologia , Adulto , Feminino , Humanos , Prazosina/uso terapêutico , Transtornos do Sono-Vigília/etiologia , Transtornos de Estresse Pós-Traumáticos/etiologiaRESUMO
We have constructed an apparatus suited for low-temperature crystal absorption measurements. The system corrects for the different optical response of the components. We have operated it between 3000 A and 24 000 A, throughout which region the error in the optical density was less than +/-0.01.